BCL2 and lung adenocarcinoma: For example, in lung adenocarcinoma, FAM111B modulates the expression of BCL2 and BAG3 to facilitate cell proliferation [11], and FAM111B exhibits peak expression levels during the early G0 phase and late S phase of the cell cycle.